Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Biochemical Pharmacology
|
August 26, 1998
Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent
K S Bauer, S C Dixon, W D Figg
Cancer Chemotherapy and Pharmacology
|
June 5, 1999
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells
S C Dixon, E A Kruger, K S Bauer, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 17, 2000
High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma
M A Rudek, C L March, K S Bauer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 22, 1999
Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway
K S Bauer, K J Cude, S C Dixon, et al.
Biomedical Chromatography : BMC
|
August 29, 2000
A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and saliva
K S Bauer, R M Lush, M A Rudek, et al.
Journal of Clinical Pharmacology
|
May 20, 1998
Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course?
P D Kroboth, M M Folan, K S Bauer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 1, 1997
Adverse effects of risperidone on eye movement activity: a comparison of risperidone and haloperidol in antipsychotic-naive schizophrenic patients
J A Sweeney, K S Bauer, M S Keshavan, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
September 15, 1999
Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: use of a single model for simultaneous determination of changing parameters
K S Bauer, E C Kohn, R M Lush, et al.
Cancer Chemotherapy and Pharmacology
|
December 8, 2004
Plasma pharmacokinetics and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors
T S Garimella, D D Ross, J L Eiseman, et al.
Journal of Pharmaceutical Sciences
|
January 6, 1999
Pharmacokinetics of thalidomide in an elderly prostate cancer population
W D Figg, S Raje, K S Bauer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Biochemical Pharmacology
|
August 26, 1998
Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent
K S Bauer, S C Dixon, W D Figg
Cancer Chemotherapy and Pharmacology
|
June 5, 1999
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells
S C Dixon, E A Kruger, K S Bauer, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 17, 2000
High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma
M A Rudek, C L March, K S Bauer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 22, 1999
Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway
K S Bauer, K J Cude, S C Dixon, et al.
Biomedical Chromatography : BMC
|
August 29, 2000
A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and saliva
K S Bauer, R M Lush, M A Rudek, et al.
Journal of Clinical Pharmacology
|
May 20, 1998
Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course?
P D Kroboth, M M Folan, K S Bauer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 1, 1997
Adverse effects of risperidone on eye movement activity: a comparison of risperidone and haloperidol in antipsychotic-naive schizophrenic patients
J A Sweeney, K S Bauer, M S Keshavan, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
September 15, 1999
Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: use of a single model for simultaneous determination of changing parameters
K S Bauer, E C Kohn, R M Lush, et al.
Cancer Chemotherapy and Pharmacology
|
December 8, 2004
Plasma pharmacokinetics and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors
T S Garimella, D D Ross, J L Eiseman, et al.
Journal of Pharmaceutical Sciences
|
January 6, 1999
Pharmacokinetics of thalidomide in an elderly prostate cancer population
W D Figg, S Raje, K S Bauer, et al.
Page
of 2